InvestorsHub Logo

mm2k

10/22/18 2:57 PM

#83667 RE: hovacre #83661

Thanks for the summary and insight.

DewDiligence

10/22/18 4:15 PM

#83682 RE: hovacre #83661

NTGN's phase-1 trial is curious insofar as it does not test for single-agent activity of NEO-PV-1: #msg-144377415.